Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTO0307 in Adults With Presbyopia
NCT07723716Phase 3Completed
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Feb 2025
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in presbyopia comparing CTO0307 with Placebo (2 arms). Primary endpoint: Percentage of Participants Gaining 3 Lines or More in Distance-Corrected Near Visual Acuity (DCNVA) at 4 weeks. Started Feb 2025; status: completed.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT07723716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07723716.